User menu

No impact of high-dose cytarabine on the outcome of patients transplanted for acute myeloblastic leukaemia in first remission

  1. Mayer Robert J., Davis Roger B., Schiffer Charles A., Berg Deborah T., Powell Bayard L., Schulman Philip, Omura George A., Moore Joseph O., McIntyre O. Ross, Frei Emil, Intensive Postremission Chemotherapy in Adults with Acute Myeloid Leukemia, 10.1056/nejm199410063311402
  2. Mitus A.J., Journal of Clinical Oncology, 13, 560 (1995)
  3. Bishop J.F., Blood, 87, 1710 (1996)
  4. Weick J.K., Blood, 88, 2841 (1996)
  5. Cole N., Blood Reviews, 11, 39 (1997)
  6. Fopp M., Fey M. F., Bacchi M., Cavalli F., Gmuer J., Jacky E., Schmid L., Tichelli A., Tobler A., Tschopp L., Von Fliedner V., Gratwohl A., 10.1023/a:1008267904952
  7. Rowe J.M., Blood, 90, 2121 (1997)
  8. Cassileth Peter A., Harrington David P., Appelbaum Frederick R., Lazarus Hillard M., Rowe Jacob M., Paietta Elisabeth, Willman Cheryl, Hurd David D., Bennett John M., Blume Karl G., Head David R., Wiernik Peter H., Chemotherapy Compared with Autologous or Allogeneic Bone Marrow Transplantation in the Management of Acute Myeloid Leukemia in First Remission, 10.1056/nejm199812033392301
  9. Ferrant A., Blood, 90, 2931 (1997)
  10. Gorin N.C., Blood, 92, 1073 (1998)
  11. Zittoun Robert A., Mandelli Franco, Willemze Roel, de Witte Theo, Labar Boris, Resegotti Luigi, Leoni Franco, Damasio Eugenio, Visani Giuseppe, Papa Giuseppe, Caronia Francesco, Hayat Marcel, Stryckmans Pierre, Rotoli Bruno, Leoni Pietro, Peetermans Marc E., Dardenne Murielle, Vegna Maria Luce, Petti Maria Concetta, Solbu Gabriel, Suciu Stefan, Autologous or Allogeneic Bone Marrow Transplantation Compared with Intensive Chemotherapy in Acute Myelogenous Leukemia, 10.1056/nejm199501263320403
  12. Reiffers J., Leukemia, 10, 1874 (1996)
  13. Harousseau J.L., Blood, 90, 2978 (1997)
  14. Burnett Alan K, Goldstone Anthony H, Stevens Richard MF, Hann Ian M, Rees John KH, Gray Richard G, Wheatley Keith, Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial, 10.1016/s0140-6736(97)09214-3
  15. Schiller G, Lee M, Miller T, Lill M, Mittal-Henkle A, Paquette R, Sawyers C, Territo M, Transplantation of autologous peripheral blood progenitor cells procured after high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemia in first remission, 10.1038/sj.leu.2400753
  16. Pavlovsky S., Fernández I., Milone G., Martinez Rolón J., Corrado C., Desmery P., Dignani C., Michelet M., Juni M., Autologous peripheral blood progenitor cell transplantation mobilized with high-dose cytarabine in acute myeloid leukemia in first complete remission, 10.1023/a:1008271624978
  17. Bloomfield C.D., Cancer Research, 58, 4173 (1998)
  18. Grimwade D., Blood, 92, 2322 (1998)
Bibliographic reference Cahn, JY. ; Ferrant, Augustin ; Labopin, M ; Sierra, J ; Blaise, D ; et. al. No impact of high-dose cytarabine on the outcome of patients transplanted for acute myeloblastic leukaemia in first remission. In: British Journal of Haematology, Vol. 110, no. 2, p. 308-314 (2000)
Permanent URL http://hdl.handle.net/2078.1/43352